These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20508374)

  • 1. Fractionated stereotactic radiotherapy as a boost treatment for tumors in the head and neck region.
    Uno T; Isobe K; Ueno N; Fukuda A; Sudo S; Shirotori H; Kitahara I; Fukushima T; Ito H
    J Radiat Res; 2010; 51(4):449-54. PubMed ID: 20508374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Yoshida K; Kotsuma T; Yamada Y; Fujiwara M; Baek S; Yoshioka Y
    Anticancer Res; 2014 Oct; 34(10):5755-9. PubMed ID: 25275085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
    Jereczek-Fossa BA; Garibaldi C; Catalano G; d'Onofrio A; De Pas T; Bocci C; Ciocca M; DePaoli F; Orecchia R
    Radiother Oncol; 2003 Jan; 66(1):49-56. PubMed ID: 12559520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dosimetry analysis of intensity-modulated and conformal radiation therapy for head and neck tumors].
    Pesznyák C; Béla D; Takácsi-Nagy Z; Major T; Polgár C
    Magy Onkol; 2015 Jun; 59(2):95-101. PubMed ID: 26035156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of single or oligo-fractionated stereotactic radiotherapy for head and neck tumors using micromultileaf collimator-based dynamic conformal arcs.
    Ohtakara K; Hayashi S; Mizuta K; Aoki M; Ando K; Okada S; Ito Y; Hoshi H
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1511-22. PubMed ID: 22526162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas.
    Baumert BG; Lutterbach J; Bernays R; Davis JB; Heppner FL
    Radiother Oncol; 2003 May; 67(2):183-90. PubMed ID: 12812849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
    Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.
    Lee DS; Kim YS; Cheon JS; Song JH; Son SH; Jang JS; Kang YN; Kang JH; Jung SL; Yoo IeR; Jang HS
    Radiat Oncol; 2012 Jun; 7():85. PubMed ID: 22691266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.
    Combs SE; Salehi-Allameh B; Habermehl D; Kessel KA; Welzel T; Debus J
    Head Neck; 2014 Jan; 36(1):22-7. PubMed ID: 23649985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands].
    Kuhnt T; Janich M; Götz U; Gerlach R; Chiricuta IC; Hänsgen G
    Strahlenther Onkol; 2006 Jun; 182(6):325-30. PubMed ID: 16703287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic radiation therapy for extracranial head and neck tumors.
    Ahn YC; Lee KC; Kim DY; Huh SJ; Yeo IH; Lim DH; Kim MK; Shin KH; Park S; Chang SH
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):501-5. PubMed ID: 10974468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
    Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
    Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer.
    Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlating planned radiation dose to the cochlea with primary site and tumor stage in patients with head and neck cancer treated with intensity-modulated radiation therapy.
    Zhang J; Qureshi MM; Kovalchuk N; Truong MT
    Med Dosim; 2014; 39(1):88-92. PubMed ID: 24485054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.